Polycystic ovary syndrome (PCOS) disrupts ovulation by creating a hormonal environment where eggs start to develop but never fully mature. About 85% to 90% of women with infrequent periods have PCOS, and the core problem is a chain reaction involving three systems: brain signaling hormones, insulin, and androgens (male-type hormones). These systems reinforce each other, making ovulation increasingly unlikely without intervention.
The Hormonal Signal Goes Wrong
Normal ovulation depends on two hormones released by the pituitary gland in the brain: LH (luteinizing hormone) and FSH (follicle-stimulating hormone). In a typical cycle, FSH rises to help a group of follicles grow, then a surge of LH triggers one mature egg to release. The ratio of LH to FSH in healthy women stays between 1:1 and 2:1.
In PCOS, that ratio gets flipped. Roughly 75% of women with PCOS have elevated LH, and 94% show an abnormally high LH-to-FSH ratio, sometimes reaching 3:1. This happens because the pituitary gland becomes overly sensitive to GnRH, the master signal from the hypothalamus. Instead of steady, cyclic pulses, LH fires in rapid, high-amplitude bursts while FSH stays suppressed. Without enough FSH, follicles can’t finish growing. Without the normal LH surge pattern, the signal to release an egg never arrives.
What locks this in place is a feedback trap. The partially developed follicles still produce estrogen, which further suppresses FSH and keeps stimulating LH. The system loses its natural rise-and-fall rhythm and settles into a flat, high-LH state. No cycle means no ovulation.
Androgens Stall Follicle Growth
The excess LH drives the ovaries to produce too many androgens, particularly testosterone. In small amounts, androgens play a normal role in early follicle development. In excess, they cause follicles to undergo premature luteinization, a process where follicle cells start behaving as if ovulation already happened before the egg is actually mature. This effectively freezes follicle development in place.
The result is visible on ultrasound: many small follicles (often called a “string of pearls”) stuck at 2 to 9 millimeters, none progressing to the 18-to-24-millimeter size needed for ovulation. These aren’t cysts in the traditional sense. They’re follicles that recruited normally but hit a wall. Updated diagnostic guidelines now consider 25 or more of these small follicles per ovary a meaningful threshold for PCOS-pattern morphology, up from the older cutoff of 12, which newer imaging technology made too sensitive.
Insulin Resistance Fuels the Cycle
Many women with PCOS have insulin resistance, meaning their cells respond poorly to insulin and the body compensates by producing more. This excess insulin doesn’t just affect blood sugar. It acts directly on ovarian cells called theca cells, which are highly sensitive to insulin and respond by ramping up androgen production. Insulin also amplifies the effect of LH on those same cells, creating a double hit.
Inside the ovary, high insulin activates pathways that push primordial follicles to start growing too early while simultaneously blocking their transition to later stages of development. This further crowds the ovary with stalled follicles. Insulin also boosts the activity of growth factors (IGF-I and IGF-II) that pile on even more androgen production. The connection between insulin and androgens is so direct that many women with PCOS notice their cycles improve when insulin resistance is addressed, even before any hormone levels change on bloodwork.
Egg Quality Is Affected, Not Just Egg Release
PCOS doesn’t only prevent eggs from being released. It changes the environment eggs develop in, which can affect their quality. The follicular fluid surrounding each egg becomes more androgenic and less estrogenic than normal. Androgens at high levels interfere with the estrogen-dependent signaling that governs how an egg matures internally, both its genetic packaging (nuclear maturation) and its cellular machinery (cytoplasmic maturation).
Women with PCOS undergoing IVF show eggs with distinctly abnormal gene expression profiles compared to women without the condition. The communication between the egg and its surrounding support cells (cumulus cells) is disrupted, and key growth factors that coordinate this dialogue are reduced from the earliest stages of follicle development. This translates to higher rates of implantation failure and pregnancy loss even when eggs are successfully retrieved and fertilized. The good news is that these effects appear to be driven by the hormonal environment rather than permanent damage to the eggs themselves, so improving that environment can improve outcomes.
What Irregular Cycles Actually Look Like
The clinical sign of disrupted ovulation is irregular periods. Oligomenorrhea, defined as a cycle length greater than 35 days, is the most common pattern. Some women go months between periods. Others have unpredictable cycles that swing between 25 and 60 days. Complete absence of periods (amenorrhea) happens when ovulation stops entirely for extended stretches. A period that does arrive after a long gap may be unusually heavy because the uterine lining has been building without the progesterone signal that normally follows ovulation.
Not every woman with PCOS stops ovulating completely. Some ovulate sporadically, which is why unplanned pregnancies still occur. But predicting those ovulations is difficult, and standard ovulation predictor kits are unreliable with PCOS. These kits detect the LH surge before ovulation, but women with PCOS often have baseline LH levels around 12 IU/mL, roughly five times higher than the average of 2.35 IU/mL in women without the condition. That elevated baseline can trigger false positives constantly, or LH may pulse erratically, producing random positive readings unrelated to actual ovulation.
How Ovulation Can Be Restored
Addressing insulin resistance is often the first step. Weight loss of even 5% to 10% of body weight can restart ovulation in some women by lowering insulin levels enough to reduce androgen production. Medications that improve insulin sensitivity work through the same pathway, pulling the trigger that starts the whole cascade back toward normal.
Supplements like D-chiro-inositol have shown promise for ovulation restoration. In clinical trials, women taking 600 to 1,200 mg daily had significantly higher ovulation rates than those on placebo, with one meta-analysis showing roughly 11 times the odds of ovulating. Myo-inositol at 4 grams daily has been studied in the context of fertility treatment and showed improved pregnancy rates compared to D-chiro-inositol alone.
When medication is needed to induce ovulation directly, letrozole has become the first-line option. A large trial published in the New England Journal of Medicine found that letrozole produced ovulation in 61.7% of treatment cycles compared to 48.3% with the older standard, clomiphene. Letrozole works by temporarily lowering estrogen, which tricks the brain into releasing more FSH, giving stalled follicles the push they need to mature. Clomiphene works through a similar but less targeted mechanism and tends to be less effective in women with higher body weight.
For women who don’t respond to oral medications, injectable hormones that deliver FSH directly can bypass the brain-level problem entirely, though these require close monitoring because the many small follicles characteristic of PCOS can all respond at once, raising the risk of ovarian hyperstimulation and multiple pregnancies.